Lisa Wilson | Investor Relations |
Scott Tarriff | President & Chief Executive Officer |
Brian Cahill | Chief Financial Officer |
Tim Lugo | William Blair |
Brandon Folkes | Cantor Fitzgerald |
David Amsellem | Piper Sandler |
Good morning, everyone. My name is Todd and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals Third Quarter 2022 Financial Results. [Operator Instructions] As a reminder, this conference call is being recorded today, November 7, 2022. It is now my pleasure to turn the floor over to Ms.